Allogeneic stem cell transplantation in myelofibrosis with myeloid metaplasia -: German multicentre analysis supports early transplantation

被引：0
|
作者：
Baurmann, H
Schleuning, M
Finke, J
Schmid, C
Bomhäuser, M
Gramatzki, M
Kobbe, G
Basara, N
Herr, W
Massenkeil, G
Schäfer-Eckart, K
Beyer, J
Siegert, W
Stelljes, M
Krüger, W
Hegenbart, U
Schwerdtfeger, R
机构：
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [1] Myeloablative allogeneic haematopoietic stem cell transplantation for myelofibrosis with myeloid metaplasia
    Ditschkowski, M.
    Keller, M. T.
    Elmaagacli, A. H.
    Trenschel, R.
    Steckel, N. K.
    Koldehoff, M.
    Schulte, C.
    Beelen, D.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S9 - S10
  • [2] Separating patients with myelofibrosis with myeloid metaplasia into risk groups for allogeneic haematopoietic cell transplantation - results of a German multicentre analysis
    Collenbusch, F.
    Schwerdtfeger, R.
    Schleuning, M.
    Schmid, C.
    Finke, J.
    Stadler, M.
    Bornhaeuser, M.
    Messerer-Schmid, D.
    Baurmann, H.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S52 - S53
  • [3] Allogeneic hematopoietic cell transplantation in myelofibrosis with myeloid metaplasia
    Hogan W.J.
    Litzow M.R.
    Tefferi A.
    Current Hematologic Malignancy Reports, 2007, 2 (1) : 34 - 42
  • [4] RISK FACTORS FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MYELOFIBROSIS WITH MYELOID METAPLASIA
    Baurmann, H.
    Collenbusch, F.
    Schmid, C.
    Finke, J.
    Stadler, M.
    Borubaeuser, M.
    Schleuning, M.
    Schwerdtfeger, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 3 - 3
  • [5] Outcome of allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia
    Ditschkowski, M
    Elmaagacli, AH
    Trenschel, R
    Thiele, J
    Beelen, DW
    BONE MARROW TRANSPLANTATION, 2003, 31 : S108 - S109
  • [6] Unrelated allogeneic hematopoietic stem cell transplantation (HSCT) for myelofibrosis with myeloid metaplasia (MMM)
    Koldehoff, M
    Basara, N
    Lentini, G
    Pohl, H
    Kiehl, MG
    Fauser, AA
    BONE MARROW TRANSPLANTATION, 2002, 29 : S166 - S166
  • [7] Fludarabine reduced conditioning followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia
    Hessling, J
    Kroeger, N
    Zabelina, T
    Krüger, W
    Renges, H
    Cordes, U
    Erttmann, R
    Zander, AR
    BONE MARROW TRANSPLANTATION, 2002, 29 : S151 - S151
  • [8] Allogeneic hematopoietic stem cell transplantation in myelofibrosis with myeloid metaplasia (MMM) - Transplantation should be performed before transfusion dependence occurs
    Baurmann, H
    Burlakowa, I
    Kaltenhaeuser, J
    Judith, D
    Heshmat, M
    Collenbusch, F
    Conradi, R
    Schleuning, M
    Schwerdtfeger, R
    BLOOD, 2004, 104 (11) : 423A - 424A
  • [9] Allogeneic Stem Cell Transplantation in Myelofibrosis
    Jain, Tania
    Mesa, Ruben A.
    Palmer, Jeanne M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1429 - 1436
  • [10] Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia
    Hessling, J
    Kröger, N
    Werner, M
    Zabelina, T
    Hansen, A
    Kordes, U
    Ayuk, FA
    Renges, H
    Panse, J
    Erttmann, R
    Zander, AR
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (03) : 769 - 772
12345